罗哌卡因抑制人肝癌细胞系Hep3B增殖、迁移和侵袭

doi:10.16352/j.issn.1001-6325.2022.03.025

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (3): 448-453.doi: 10.16352/j.issn.1001-6325.2022.03.025

罗哌卡因抑制人肝癌细胞系Hep3B增殖、迁移和侵袭

孙全鹏^1*, 樊超², 展德玺³, 范怡明¹, 孙伟峰¹

1.郑州大学第一附属医院麻醉科, 河南郑州 450044;
2.郑州市骨科医院麻醉科, 河南郑州 450044;
3.郸城县人民医院麻醉科, 河南周口 477150

收稿日期:2020-11-16 修回日期:2021-08-06 出版日期:2022-03-05 发布日期:2022-03-04
通讯作者: ^* srja34@163.com
基金资助:
河南省医学科技攻关计划省部共建项目(201701035)

Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B

SUN Quan-peng^1*, FAN Chao², ZHAN De-xi³, FAN Yi-ming¹, SUN Wei-feng¹

1. Depatrment of Anesthesiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450044;
2. Depatrment of Anesthesiology, Zhengzhou Orthopedic Hospital, Zhengzhou 450044;
3. Depatrment of Anesthesiology, Dancheng People's Hospital, Zhoukou 477150, China

Received:2020-11-16 Revised:2021-08-06 Online:2022-03-05 Published:2022-03-04
Contact: ^* srja34@163.com

摘要/Abstract

摘要： 目的研究罗哌卡因对人肝癌细胞系Hep3B生物学行为的影响,并探讨其分子机制。方法设置对照组、罗哌卡因组、si-NC组、si-LINC00853组、pcDNA-NC组、pcDNA-LINC00853组、(罗哌卡因+pcDNA-NC)组、(罗哌卡因+pcDNA-LINC00853)组。采用细胞计数试剂盒(CCK-8法)、Transwell小室法、RT-qPCR检测细胞增殖、迁移、侵袭以及LINC00853表达。Western blot分析细胞增殖核抗原(PCNA)、基质金属蛋白酶2(MMP2)和MMP9蛋白的表达水平。结果与对照组比较,罗哌卡因组Hep3B细胞增殖抑制率升高,迁移和侵袭细胞数减少,PCNA、MMP2和MMP9以及LINC00853表达显著降低(P＜0.05)。与si-NC组比较,si-LINC00853组Hep3B细胞增殖抑制率升高,迁移和侵袭细胞数减少,PCNA、MMP2和MMP9蛋白表达降低(P＜0.05)。与pcDNA-NC组比较,pcDNA-LINC00853组Hep3B细胞增殖抑制率降低,迁移和侵袭细胞数增多,PCNA、MMP2和MMP9蛋白表达升高(P＜0.05)。与(罗哌卡因+pcDNA-NC)组比较,(罗哌卡因+pcDNA-LINC00853)组Hep3B细胞增殖抑制率降低,迁移和侵袭细胞数增多,PCNA、MMP2和MMP9蛋白表达升高(P＜0.05)。结论罗哌卡因可抑制肝癌细胞系Hep3B的增殖、迁移和侵袭,其机制可能与下调LINC00853表达有关。

关键词: 罗哌卡因, LINC00853, 肝癌, 增殖, 迁移, 侵袭

Abstract: Objective To study the effects of ropivacaine on the biological behaviour of liver cancer cell line Hep3B and to explore its molecular mechanism. Methods Hep3B cells were divided into the control group, ropivacaine group, si-NC group, si-LINC00853 group, pcDNA-NC group, pcDNA-LINC00853 group,(ropivacaine+pcDNA-NC) group and (ropivacaine +pcDNA-LINC00853) group. Cell Counting Kit(CCK-8), Transwell assays, and RT-qPCR were applied to detect cell proliferation, migration, invasion and LINC00853 expression. Western blot was used to analyze the expression of proliferating cell nuclear antigen (PCNA), matrix metalloproteinase 2(MMP2) and MMP9 proteins. Results Compared with the NC group, the proliferation inhibition rate of Hep3B cells in the ropivacaine group was elevated, cell migration and invasion were inhibited. The expression of PCNA, MMP2, MMP9 and LINC00853 was reduced (P＜0.05). Compared with the si-NC group, the proliferation inhibition rate of Hep3B cells in the si-LINC00853 group was elevated, cell migration and invasion were reduced and the expression of PCNA, MMP2, MMP9 protein was decreased (P＜0.05). Compared with the pcDNA-NC group, the proliferation inhibition of Hep3B cells in the pcDNA-LINC00853 group was reduced, cell migration and invasion were increased. The expression of PCNA, MMP2, and MMP9 protein was increased (P＜0.05). Compared with the (ropivacaine+ pcDNA-NC) group, the proliferation inhibitio of Hep3B cells in the (ropivacaine+ pcDNA-LINC00853) group was reduced, cell migration and invasion were increased and the expression of PCNA, MMP2 and MMP9 protein increased (P＜0.05). Conclusions Ropivacaine can inhibit liver cancer cell line Hep3B proliferation, migration and invasion. Its mechanism may be related to the down-regulation of LINC00853 expression.

Key words: ropivacaine, LINC00853, liver cancer, proliferation, migration, invasion

中图分类号:

R735.7

孙全鹏, 樊超, 展德玺, 范怡明, 孙伟峰. 罗哌卡因抑制人肝癌细胞系Hep3B增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(3): 448-453.

SUN Quan-peng, FAN Chao, ZHAN De-xi, FAN Yi-ming, SUN Wei-feng. Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B[J]. Basic & Clinical Medicine, 2022, 42(3): 448-453.

参考文献

[1]蔡秀军, 郑强, 蒋广宜. 肝癌外科治疗的现状和展望[J]. 中华外科杂志, 2019, 57: 494-499.
[2]Tedore T. Regional anaesthesia and analgesia: relationship to cancer recurrence and survival[J]. Br J Anaesth, 2015, 115: 34-45.
[3]Bharati SJ, Chowdhury T, Bergese SD, et al. Anesthetics impact on cancer recurrence: What do we know?[J]. J Cancer Res Ther, 2016, 12: 464-468.
[4]Wang W, Zhu M, Xu Z, et al. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity[J]. Biol Res, 2019, 52: 36-46.
[5]Kim SS, Baek GO, Ahn HR, et al. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma[J]. Mol Oncol, 2020, 14: 2646-2659.
[6]Yang W, Cai J, Zhang H, et al. Effects of lidocaine and ropivacaine on gastric cancer cells through down-regulation of ERK1/2 phosphorylation in vitro[J]. Anticancer Res, 2018, 38: 6729-6735.
[7]Qin A, Liu Q, Wang J. Ropivacaine inhibits prolifera-tion, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression[J]. Drug Dev Res, 2020, 81: 700-707.
[8]Zhu G, Zhang L, Dan J, et al. Differential effects and mechanisms of local anesthetics on esophageal carcinoma cell migration, growth, survival and chemosensitivity[J]. BMC Anesthesiol, 2020, 20: 126-136.
[9]Shan K, Wang Y, Hua H, et al. Ginsenoside Rg3 combined with oxaliplatin inhibits the proliferation and promotes apoptosis of hepatocellular carcinoma cells via downregulating PCNA and cyclin D1[J]. Biol Pharm Bull, 2019, 42: 900-905.
[10]陈素华, 马天江, 张智慧, 等. 淫羊藿苷通过下调转移相关蛋白2抑制MGC803细胞的增殖、迁移和侵袭[J]. 基础医学与临床, 2019, 39: 1587-1591.
[11]Liu Y, Yang Y, Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer[J]. Biochem Cell Biol, 2018, 96: 38-43.
[12]Zhu J, Han S. Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway[J]. Am J Transl Res, 2019, 11: 5404-5416.

[1]	肖艳红, 姜明东, 林叶远, 冉灿, 梁博. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移[J]. 基础医学与临床, 2024, 44(9): 1229-1235.
[2]	李顺乐, 李蓉, 田亚亚, 冉小丽, 赵延培, 徐蒙. 血清KLF5和actinin-4水平与肝细胞肝癌肝动脉化疗栓塞术治疗预后的关系[J]. 基础医学与临床, 2024, 44(9): 1284-1289.
[3]	姚安军, 陈凌子, 金惠仙. 二十二碳六烯酸抑制人结肠癌细胞系HT-29增殖[J]. 基础医学与临床, 2024, 44(8): 1107-1112.
[4]	郑红, 陈晓霞, 韩李周, 陈苗, 皇甫娟. 降低lncRNA-RMRP表达抑制人肺癌细胞系A549的增殖和侵袭[J]. 基础医学与临床, 2024, 44(7): 974-978.
[5]	曹清文, 祁琳, 禹博, 田晨晨, 袁海宁, 王越. 红景天苷促进人血管内皮细胞系EA.hy926增殖与迁移[J]. 基础医学与临床, 2024, 44(7): 925-930.
[6]	张鹏举, 李杰, 张梦迪, 孙少科, 许寅喆. KAT8通过增强METTL3表达促进结直肠癌细胞系增殖[J]. 基础医学与临床, 2024, 44(7): 931-939.
[7]	高寅洁, 童安莉. 醛固酮产生腺瘤中细胞死亡和增殖机制[J]. 基础医学与临床, 2024, 44(6): 758-762.
[8]	王婷婷, 萧宁, 林佃新, 董海涛. 大蒜素抑制口腔癌细胞系CAL27的增殖[J]. 基础医学与临床, 2024, 44(5): 673-676.
[9]	贾安娜, 郭金鑫, 张璇, 战世佳, 于永波, 郭永丽, 常艳. TMEFF1对神经母细胞瘤细胞系增殖的调控[J]. 基础医学与临床, 2024, 44(5): 637-644.
[10]	宋可, 宋柯, 李静宇, 马伟, 杨晓葵. 小鼠卵母细胞减数分裂中心粒蛋白SAS-6的表达和亚细胞分布[J]. 基础医学与临床, 2024, 44(5): 651-657.
[11]	梁香存, 魏小雨, 梁健, 王庆, 耿广. 安罗替尼通过调控miR-16-5p/PD-1轴抑制人非小细胞肺癌细胞系增殖并促进凋亡[J]. 基础医学与临床, 2024, 44(4): 503-512.
[12]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[13]	郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.
[14]	李娜, 李涛, 杨冬梨, 姚媛. 和厚朴酚抑制人脂肪间充质干细胞增殖[J]. 基础医学与临床, 2024, 44(4): 483-488.
[15]	张婧, 杨自更, 蔡文琴, 曹维维, 韦红梅, 薛茜茜, 吴宾. 抑制抗增殖蛋白2增强非小细胞肺癌细胞系A549对厄洛替尼敏感性[J]. 基础医学与临床, 2024, 44(3): 325-332.

罗哌卡因抑制人肝癌细胞系Hep3B增殖、迁移和侵袭

Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价